Lista de obras - Alice Tseng - Dominio Público Uruguay

Advances in human immunodeficiency virus therapeutics.

artículo científico publicado en 2006

Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients

artículo científico publicado en 2013

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment

artículo científico publicado en 2016

Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapy

artículo científico publicado en 2003

Cobicistat Versus Ritonavir: Similar Pharmacokinetic Enhancers But Some Important Differences

artículo científico publicado en 2017

Comparative tolerability of therapies for cytomegalovirus retinitis

artículo científico publicado en 1999

Critical Review: Review of the Efficacy, Safety, and Pharmacokinetics of Raltegravir in Pregnancy.

artículo científico publicado en 2016

Development of a collaborative professional group for HIV pharmacists: experience from the Canadian HIV/AIDS Pharmacists Network

article

Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms.

artículo científico publicado en 2016

Drug interactions between antiretrovirals and hormonal contraceptives.

artículo científico publicado en 2013

Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy.

artículo científico

Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis

artículo científico publicado en 1995

Handbook and website on HIV drug therapy

article

Hepatotoxicity and potential drug interaction with ledipasvir/sofosbuvir in HIV/HCV infected patients.

artículo científico publicado en 2016

High rate of discontinuations of highly active antiretroviral therapy as a result of antiretroviral intolerance in clinical practice: missed opportunities for adherence support?

artículo científico publicado en 2002

Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.

artículo científico

Increase in international normalized ratio after switching from atazanavir/ritonavir to darunavir/cobicistat in a patient on warfarin: boosters are not always equal

artículo científico publicado en 2017

Interactions between antiretrovirals and antineoplastic drug therapy.

artículo científico publicado en 2005

Iritis associated with intravenous cidofovir

artículo científico publicado en 1999

Managing drug interactions in HIV-infected adults with comorbid illness

artículo científico publicado en 2015

New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir.

artículo científico publicado en 2009

Non-nucleoside reverse transcriptase inhibitor failure impairs HIV-RNA responses to efavirenz-containing salvage antiretroviral therapy.

artículo científico publicado en 2001

Precipitous declines in hemoglobin levels associated with combination zidovudine and lamivudine therapy.

artículo científico publicado en 1998

Probable interaction between efavirenz and cyclosporine

artículo científico publicado en 2002

Psychiatric treatment considerations with direct acting antivirals in hepatitis C ⬇️

artículo científico publicado el 14 de mayo de 2013

Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen

artículo científico publicado en 2007

Safety and efficacy of CHOP for treatment of diffuse large B-cell lymphoma with different combination antiretroviral therapy regimens: SCULPT study

artículo científico publicado en 2013

Short communication: effects of age on virologic suppression and CD4 cell response in HIV-positive patients initiating combination antiretroviral therapy.

artículo científico

Significant interaction between activated charcoal and antiretroviral therapy leading to subtherapeutic drug concentrations, virological breakthrough and development of resistance.

artículo científico publicado en 2013

Significant interactions with new antiretrovirals and psychotropic drugs.

artículo científico publicado en 1999

Steady-state pharmacokinetics and tolerability of indinavir-lopinavir/r combination therapy in antiretroviral-experienced patients

artículo científico publicado en 2005

Successful use of the potent enzyme inducer enzalutamide in a treatment-experienced HIV-positive male with prostate cancer

article

The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.

artículo científico publicado en 2015

Therapeutic drug monitoring in treatment-experienced HIV-infected patients receiving darunavir-based salvage regimens: A case series.

artículo científico publicado en 2018

Lista de obras de Alice Tseng

Advances in human immunodeficiency virus therapeutics.

Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment

Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapy

Cobicistat Versus Ritonavir: Similar Pharmacokinetic Enhancers But Some Important Differences

Comparative tolerability of therapies for cytomegalovirus retinitis

Critical Review: Review of the Efficacy, Safety, and Pharmacokinetics of Raltegravir in Pregnancy.

Development of a collaborative professional group for HIV pharmacists: experience from the Canadian HIV/AIDS Pharmacists Network

Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms.

Drug interactions between antiretrovirals and hormonal contraceptives.

Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy.

Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis

Handbook and website on HIV drug therapy

Hepatotoxicity and potential drug interaction with ledipasvir/sofosbuvir in HIV/HCV infected patients.

High rate of discontinuations of highly active antiretroviral therapy as a result of antiretroviral intolerance in clinical practice: missed opportunities for adherence support?

Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.

Increase in international normalized ratio after switching from atazanavir/ritonavir to darunavir/cobicistat in a patient on warfarin: boosters are not always equal

Interactions between antiretrovirals and antineoplastic drug therapy.

Iritis associated with intravenous cidofovir

Managing drug interactions in HIV-infected adults with comorbid illness

New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir.

Non-nucleoside reverse transcriptase inhibitor failure impairs HIV-RNA responses to efavirenz-containing salvage antiretroviral therapy.

Precipitous declines in hemoglobin levels associated with combination zidovudine and lamivudine therapy.

Probable interaction between efavirenz and cyclosporine

Psychiatric treatment considerations with direct acting antivirals in hepatitis C ⬇️

Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen

Safety and efficacy of CHOP for treatment of diffuse large B-cell lymphoma with different combination antiretroviral therapy regimens: SCULPT study

Short communication: effects of age on virologic suppression and CD4 cell response in HIV-positive patients initiating combination antiretroviral therapy.

Significant interaction between activated charcoal and antiretroviral therapy leading to subtherapeutic drug concentrations, virological breakthrough and development of resistance.

Significant interactions with new antiretrovirals and psychotropic drugs.

Steady-state pharmacokinetics and tolerability of indinavir-lopinavir/r combination therapy in antiretroviral-experienced patients

Successful use of the potent enzyme inducer enzalutamide in a treatment-experienced HIV-positive male with prostate cancer

The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.

Therapeutic drug monitoring in treatment-experienced HIV-infected patients receiving darunavir-based salvage regimens: A case series.